Xiamen Amoytop Biotech Co Ltd (688278) — Capital Reinvestment Ratio
Xiamen Amoytop Biotech Co Ltd (688278) has a Capital Reinvestment Ratio of 0.13x as of September 2023, meaning it reinvests 0% of its operating cash flow (CN¥332.29 Million) in capital expenditures (CN¥43.00 Million). See 688278 net asset quality score to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Xiamen Amoytop Biotech Co Ltd Capital Reinvestment Ratio (2016–2024)
This chart tracks Xiamen Amoytop Biotech Co Ltd's Capital Reinvestment Ratio across 8 annual periods. Check cash flow reinvestment rate of Xiamen Amoytop Biotech Co Ltd to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Xiamen Amoytop Biotech Co Ltd (2016–2024)
Year-by-year Capital Reinvestment Ratio for Xiamen Amoytop Biotech Co Ltd from 2016 to 2024. For live market cap and broader valuation context, see Xiamen Amoytop Biotech Co Ltd stock valuation.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.58x | CN¥430.63 Million | CN¥251.35 Million | ▲ +22.3% |
| 2023 | 0.48x | CN¥512.10 Million | CN¥244.48 Million | ▼ -20.9% |
| 2022 | 0.60x | CN¥363.16 Million | CN¥219.17 Million | ▼ -25.8% |
| 2021 | 0.81x | CN¥234.78 Million | CN¥190.93 Million | ▼ -36.6% |
| 2020 | 1.28x | CN¥92.61 Million | CN¥118.81 Million | ▲ +252.9% |
| 2019 | 0.36x | CN¥123.30 Million | CN¥44.83 Million | ▲ +122.0% |
| 2018 | 0.16x | CN¥89.15 Million | CN¥14.60 Million | ▼ -92.0% |
| 2016 | 2.05x | CN¥42.43 Million | CN¥87.03 Million | — |